Association of Smokeless Tobacco Use With Incident Peripheral Artery Disease: Results From the Atherosclerotic Risk in Communities Study.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
05 2023
Historique:
received: 13 07 2022
revised: 03 01 2023
accepted: 04 01 2023
pmc-release: 01 05 2024
medline: 25 4 2023
pubmed: 23 1 2023
entrez: 22 1 2023
Statut: ppublish

Résumé

Cigarette smoking is associated with an increased risk for peripheral artery disease. It is unknown whether smokeless tobacco, a noncombustible form of tobacco exposure, is also associated with increased peripheral artery disease risk. Using data from the Atherosclerosis Risk in Communities study, we tested the hypothesis that the use of smokeless tobacco is associated with a higher risk of developing peripheral artery disease. Participants with peripheral artery disease at baseline were excluded. Smokeless tobacco use was assessed 3 times from 1987 to 1995, and peripheral artery disease events accrued from 1987 to 2018. Smokeless tobacco was modeled as a time-dependent exposure in Cox regression models. Analyses were completed in 2021. This study included 14,344 participants with a baseline mean (SD) age of 54.1 (5.7) years; 54.8% were female, and 26.4% were Black. There were 635 incident peripheral artery disease events over a median follow-up of 27.6 years (maximum of 32.1 years). The peripheral artery disease incidence rate was 4.44 per 1,000 person-years among those who used smokeless tobacco compared with 1.74 per 1,000 person-years for those who did not. The hazard ratio for current versus never smokeless tobacco use was 1.94 (95% CI=1.31, 2.88) after adjustment for sociodemographic characteristics and cigarette smoking. Peripheral artery disease incidence rate among those currently using smokeless tobacco was similar to that of those who currently smoke cigarette (3.39 per 1,000 person-years). Current smokeless tobacco use was associated with high rates of peripheral artery disease, similar to cigarette smoking. Future research should evaluate the effect of cessation of noncombustible tobacco on incident peripheral artery disease.

Identifiants

pubmed: 36682917
pii: S0749-3797(23)00002-8
doi: 10.1016/j.amepre.2023.01.001
pmc: PMC10121742
mid: NIHMS1865713
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

728-733

Subventions

Organisme : NHLBI NIH HHS
ID : 75N92022D00002
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92022D00004
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL159246
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92022D00003
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92022D00005
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92022D00001
Pays : United States

Informations de copyright

Copyright © 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Références

Am J Epidemiol. 2010 Sep 1;172(5):600-5
pubmed: 20688904
Cancer Causes Control. 2005 May;16(4):347-58
pubmed: 15953977
Am J Epidemiol. 2014 Oct 1;180(7):749-54
pubmed: 25125690
Eur J Prev Cardiol. 2016 Dec;23(18):1970-1981
pubmed: 27256827
JAMA Netw Open. 2021 Oct 1;4(10):e2130924
pubmed: 34665244
J Am Coll Cardiol. 2021 Jun 15;77(23):2939-2959
pubmed: 34112321
Circulation. 2010 Oct 12;122(15):1520-44
pubmed: 20837898
J Am Coll Cardiol. 2019 Jul 30;74(4):498-507
pubmed: 31345423
Arch Intern Med. 2004 Sep 27;164(17):1845-9
pubmed: 15451758
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681
MMWR Morb Mortal Wkly Rep. 2016 Dec 09;65(48):1357-1363
pubmed: 27932780
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Circulation. 2009 Nov 24;120(21):2053-61
pubmed: 19901192

Auteurs

Jeremy R Van't Hof (JR)

Lillehei Heart Institute & Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota. Electronic address: vanth008@umn.edu.

Wendy Wang (W)

Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.

Kunihiro Matsushita (K)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.

Gerardo Heiss (G)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

Aaron R Folsom (AR)

Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.

Rachel Widome (R)

Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.

Pamela L Lutsey (PL)

Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH